Dr. Yap’s main research focuses on the first-in-human and combinatorial development of molecularly targeted agents and immunotherapies, and their acceleration through clinical studies using novel predictive and pharmacodynamics biomarkers.
This person is not in the org chart
This person is not in any teams
This person is not in any offices